Chronic Pancreatitis: Pediatric and Adult Cohorts Show Similarities in Disease Progress Despite Different Risk Factors
- PMID: 30897605
- PMCID: PMC6492264
- DOI: 10.1097/MPG.0000000000002279
Chronic Pancreatitis: Pediatric and Adult Cohorts Show Similarities in Disease Progress Despite Different Risk Factors
Abstract
Objectives: The aim of the present study was to investigate the natural history of chronic pancreatitis (CP); patients in the North American Pancreatitis Study2 (NAPS2, adults) and INternational Study group of Pediatric Pancreatitis: In search for a cuRE (INSPPIRE, pediatric) were compared.
Methods: Demographics, risk factors, disease duration, management and outcomes of 224 children and 1063 adults were compared using appropriate statistical tests for categorical and continuous variables.
Results: Alcohol was a risk in 53% of adults and 1% of children (P < 0.0001); tobacco in 50% of adults and 7% of children (P < 0.0001). Obstructive factors were more common in children (29% vs 19% in adults, P = 0.001). Genetic risk factors were found more often in children. Exocrine pancreatic insufficiency was similar (children 26% vs adult 33%, P = 0.107). Diabetes was more common in adults than children (36% vs 4% respectively, P < 0.0001). Median emergency room visits, hospitalizations, and missed days of work/school were similar across the cohorts. As a secondary analysis, NAPS2 subjects with childhood onset (NAPS2-CO) were compared with INSPPIRE subjects. These 2 cohorts were more similar than the total INSPPIRE and NAPS2 cohorts, including for genetic risk factors. The only risk factor significantly more common in the NAPS2-CO cohort compared with the INSPPIRE cohort was alcohol (9% NAPS2-CO vs 1% INSPPIRE cohorts, P = 0.011).
Conclusions: Despite disparity in age of onset, children and adults with CP exhibit similarity in demographics, CP treatment, and pain. Differences between groups in radiographic findings and diabetes prevalence may be related to differences in risk factors associated with disease and length of time of CP.
Conflict of interest statement
Conflicts of Interest
Dr. Mark Lowe is on the Board of Directors of the National Pancreas Foundation; he receives royalties from Millipore Inc and UpToDate. Drs. Tanja Gonska and Michael Wilschanski received a research grant from Vertex Pharmaceuticals. Dr. Sohail Husain owns equity in PrevCon. Dr. John Pohl is on the speaker’s bureau for Medical Education Resources, Inc.; Dr. Melena Bellin is a consultant for AbbVie Inc and ARIEL Precision Medicine. Dr. Sarah Jane Schwarzenberg is a consultant for AbbVie, Inc. Dr. Aliye Uc is a member of American Board of Pediatrics, Subboard of Pediatric Gastroenterology. The other authors declare no conflicts of interest.
References
-
- Yadav D, Timmons L, Benson JT, et al. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol 2011;106:2192–9. - PubMed
Publication types
MeSH terms
Grants and funding
- R56 DK061451/DK/NIDDK NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- UL1 RR024153/RR/NCRR NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- UL1 TR002538/TR/NCATS NIH HHS/United States
- P30 CA086862/CA/NCI NIH HHS/United States
- U01 DK108306/DK/NIDDK NIH HHS/United States
- U01 DK108334/DK/NIDDK NIH HHS/United States
- R01 DK077906/DK/NIDDK NIH HHS/United States
- R01 DK097820/DK/NIDDK NIH HHS/United States
- UL1 TR000442/TR/NCATS NIH HHS/United States
- U01 DK108326/DK/NIDDK NIH HHS/United States
- P30 DK054759/DK/NIDDK NIH HHS/United States
- R21 DK096327/DK/NIDDK NIH HHS/United States
- U01 DK108327/DK/NIDDK NIH HHS/United States
- U01 DK108320/DK/NIDDK NIH HHS/United States
- R01 DK061451/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous